161 related articles for article (PubMed ID: 30333913)
21. Endothelial-Mesenchymal Transition Drives Expression of CD44 Variant and xCT in Pulmonary Hypertension.
Isobe S; Kataoka M; Endo J; Moriyama H; Okazaki S; Tsuchihashi K; Katsumata Y; Yamamoto T; Shirakawa K; Yoshida N; Shimoda M; Chiba T; Masuko T; Hakamata Y; Kobayashi E; Saya H; Fukuda K; Sano M
Am J Respir Cell Mol Biol; 2019 Sep; 61(3):367-379. PubMed ID: 30897333
[TBL] [Abstract][Full Text] [Related]
22. xCT Inhibition Increases Sensitivity to Vorinostat in a ROS-Dependent Manner.
Miyamoto K; Watanabe M; Boku S; Sukeno M; Morita M; Kondo H; Sakaguchi K; Taguchi T; Sakai T
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32235498
[TBL] [Abstract][Full Text] [Related]
23. Sulfasalazine, a potent cystine-glutamate transporter inhibitor, enhances osteogenic differentiation of canine adipose-derived stem cells.
Itoh H; Tani K; Sunahara H; Nemoto Y; Nakaichi M; Horikirizono H; Itamoto K
J Vet Med Sci; 2023 Nov; 85(11):1237-1244. PubMed ID: 37866885
[TBL] [Abstract][Full Text] [Related]
24. Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function.
Chen L; Li X; Liu L; Yu B; Xue Y; Liu Y
Oncol Rep; 2015 Mar; 33(3):1465-74. PubMed ID: 25585997
[TBL] [Abstract][Full Text] [Related]
25. Structure-Activity-Relationship-Aided Design and Synthesis of xCT Antiporter Inhibitors.
Cirillo D; Sarowar S; Øyvind Enger P; Bjørsvik HR
ChemMedChem; 2021 Sep; 16(17):2650-2668. PubMed ID: 33847044
[TBL] [Abstract][Full Text] [Related]
26. Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion.
Sleire L; Skeie BS; Netland IA; Førde HE; Dodoo E; Selheim F; Leiss L; Heggdal JI; Pedersen PH; Wang J; Enger PØ
Oncogene; 2015 Dec; 34(49):5951-9. PubMed ID: 25798841
[TBL] [Abstract][Full Text] [Related]
27. PKCα Inhibition as a Strategy to Sensitize Neuroblastoma Stem Cells to Etoposide by Stimulating Ferroptosis.
Monteleone L; Speciale A; Valenti GE; Traverso N; Ravera S; Garbarino O; Leardi R; Farinini E; Roveri A; Ursini F; Cantoni C; Pronzato MA; Marinari UM; Marengo B; Domenicotti C
Antioxidants (Basel); 2021 Apr; 10(5):. PubMed ID: 33924765
[TBL] [Abstract][Full Text] [Related]
28. Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway.
Chen RS; Song YM; Zhou ZY; Tong T; Li Y; Fu M; Guo XL; Dong LJ; He X; Qiao HX; Zhan QM; Li W
Oncogene; 2009 Jan; 28(4):599-609. PubMed ID: 19015640
[TBL] [Abstract][Full Text] [Related]
29. Overcoming Therapeutic Challenges for Pancreatic Ductal Adenocarcinoma with xCT Inhibitors.
Vucetic M; Daher B; Cassim S; Parks S; Pouyssegur J
Adv Exp Med Biol; 2021; 1301():7-24. PubMed ID: 34370285
[TBL] [Abstract][Full Text] [Related]
30. Iron regulates L-cystine uptake and glutathione levels in lens epithelial and retinal pigment epithelial cells by its effect on cytosolic aconitase.
Lall MM; Ferrell J; Nagar S; Fleisher LN; McGahan MC
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):310-9. PubMed ID: 18172108
[TBL] [Abstract][Full Text] [Related]
31. xCT expression modulates cisplatin resistance in Tca8113 tongue carcinoma cells.
Zhang P; Wang W; Wei Z; Xu LI; Yang X; DU Y
Oncol Lett; 2016 Jul; 12(1):307-314. PubMed ID: 27347143
[TBL] [Abstract][Full Text] [Related]
32. The proteasome inhibitor lactacystin enhances GSH synthesis capacity by increased expression of antioxidant components in an Nrf2-independent, but p38 MAPK-dependent manner in rat colorectal carcinoma cells.
Huseby NE; Ravuri C; Moens U
Free Radic Res; 2016; 50(1):1-13. PubMed ID: 26530909
[TBL] [Abstract][Full Text] [Related]
33. Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema.
Sehm T; Fan Z; Ghoochani A; Rauh M; Engelhorn T; Minakaki G; Dörfler A; Klucken J; Buchfelder M; Eyüpoglu IY; Savaskan N
Oncotarget; 2016 Jun; 7(24):36021-36033. PubMed ID: 27074570
[TBL] [Abstract][Full Text] [Related]
34. Neurodegeneration and the Brain Tumor Microenvironment. [corrected].
Savaskan NE; Fan Z; Broggini T; Buchfelder M; Eyüpoglu IY
Curr Neuropharmacol; 2015; 13(2):258-65. PubMed ID: 26411769
[TBL] [Abstract][Full Text] [Related]
35. Negative regulation of osteoblastogenesis through downregulation of runt-related transcription factor-2 in osteoblastic MC3T3-E1 cells with stable overexpression of the cystine/glutamate antiporter xCT subunit.
Uno K; Takarada T; Takarada-Iemata M; Nakamura Y; Fujita H; Hinoi E; Yoneda Y
J Cell Physiol; 2011 Nov; 226(11):2953-64. PubMed ID: 21302293
[TBL] [Abstract][Full Text] [Related]
36. Establishment of a New Canine Inflammatory Mammary Carcinoma Cell Line and Analysis of its Cystine-glutamate Transporter Subunit Expression.
Itoh H; Naruse R; Tani K; Sunahara H; Nemoto Y; Nakaichi M; Iseri T; Horikirizono H; Itamoto K
J Vet Res; 2022 Jun; 66(2):273-279. PubMed ID: 35892110
[TBL] [Abstract][Full Text] [Related]
37. Suppression of the xCT-CD44v antiporter system sensitizes triple-negative breast cancer cells to doxorubicin.
Wang F; Yang Y
Breast Cancer Res Treat; 2014 Aug; 147(1):203-10. PubMed ID: 25085754
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effects of levetiracetam target xCT in astrocytes in parkinsonian mice.
Miyazaki I; Murakami S; Torigoe N; Kitamura Y; Asanuma M
J Neurochem; 2016 Jan; 136(1):194-204. PubMed ID: 26485447
[TBL] [Abstract][Full Text] [Related]
39. Sulfasalazine Sensitizes Polyhematoporphyrin-Mediated Photodynamic Therapy in Cholangiocarcinoma by Targeting xCT.
Zheng YW; Miao XY; Xiong L; Chen B; Kong FH; Zhou JJ; Liu ZT; Wen Y; Zhang ZJ; Zou H
Front Pharmacol; 2021; 12():723488. PubMed ID: 34483935
[TBL] [Abstract][Full Text] [Related]
40. Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma.
Guo W; Zhao Y; Zhang Z; Tan N; Zhao F; Ge C; Liang L; Jia D; Chen T; Yao M; Li J; He X
Cancer Lett; 2011 Dec; 312(1):55-61. PubMed ID: 21906871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
